For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Chdi Foundation, Inc.

USPTO Granted Patents = 53

CIPO Patents = 1

EPO Patents = 19

Forward Citations = 164

Loading Chart...

Loading Chart...

97 inventors (with patents filed for the assignee):

Celia Dominguez (50 out of 78 patents)

Michael Edward Prime (24 out of 25 patents)

Leticia M Toledo-Sherman (17 out of 17 patents)

4. Peter David Johnson (17 out of 28 patents)

5. John Wityak (16 out of 49 patents)

6. Christopher John Brown (16 out of 24 patents)

7. Jonathan Bard (13 out of 13 patents)

8. Christopher A Luckhurst (13 out of 13 patents)

9. Alan Findlay Haughan (13 out of 29 patents)

10. Perla Breccia (12 out of 12 patents)

11. Andrew J Stott (12 out of 12 patents)

12. Daniel Clark-Frew (11 out of 11 patents)

13. William Mitchell (10 out of 10 patents)

14. Roland W Bürli (10 out of 18 patents)

15. Stephen Martin Courtney (9 out of 52 patents)

Core Competencies:

Rho Kinase Inhibitors

HTT Modulators

Huntingtin Protein Imaging

Kynurenine-3-Monooxygenase Inhibitors

Histone Deacetylase Inhibitors

Zinc Finger Proteins

Heterobiaryl Compounds

Heterocyclic Compounds

Transglutaminase TG2 Inhibitors

Pharmaceutical Compositions

Compounds for Huntington's Disease

Imaging Agents

53 patents: Sort by Forward Citations

1. 12428413 - Rho kinase inhibitors and compositions and methods of use thereof (2025-09-30),

2. 12281116 - HTT modulators for treating Huntington's disease (2025-04-21),

3. 12258355 - Probes for imaging huntingtin protein (2025-03-25),

4. 12083108 - Compounds for targeting mutant huntingtin protein and uses thereof (2024-09-10),

5. 12036292 - Heterobiaryl compounds and imaging agents for imaging huntingtin protein (2024-07-16),

6. 12036291 - Probes for imaging huntingtin protein (2024-07-16),

7. 11992535 - Compounds and probes for imaging huntingtin protein (2024-05-28),

8. 11918662 - Heterocyclic compounds and imaging agents for imaging huntingtin protein (2024-03-05),

9. 11851446 - Probes for imaging Huntingtin protein (2023-12-26),

10. 11806346 - HTT modulators for treating Huntington's disease (2023-11-07),

11. 11685734 - ATM kinase inhibitors and compositions and methods of use thereof (2023-06-27),

12. 11421007 - Zinc finger protein compositions for modulation of huntingtin (Htt) (2022-08-23),

13. 11389438 - Compounds for targeting mutant huntingtin protein and uses thereof (2022-07-19),

14. 11344637 - Probes for imaging huntingtin protein (2022-05-31),

15. 11173156 - Solid forms of a kynurenine-3-monooxygenase inhibitor (2021-11-16),

CHDI Foundation, Inc. is a not-for-profit biomedical research organization focused on discovering drugs that can slow the progression of Huntington’s disease (HD). Their mission is to develop therapies that will measurably improve the lives of those affected by HD. They work collaboratively with academic institutions, pharmaceutical companies, and other organizations to accelerate the translation of scientific discoveries into therapeutic approaches for HD.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

53 Patents

#152 in New York, NY

#367 in New York

#6,447 in US

#12,953 in the World

New York, NY, United States of America

Chdi Foundation, Inc.

Forward Citations = 164

97 inventors:

Celia Dominguez (50 out of 78 patents)

Michael Edward Prime (24 out of 25 patents)

Leticia M Toledo-Sherman (17 out of 17 patents)

4. Peter David Johnson (17 out of 28 patents)

5. John Wityak (16 out of 49 patents)

Please report any incorrect information to support@idiyas.com

Loading…